{
    "2021-04-02": [
        [
            {
                "time": "",
                "original_text": "销售人员工资减半，站在疫情的风口里，华兰生物有点凉",
                "features": {
                    "keywords": [
                        "销售人员",
                        "工资减半",
                        "疫情",
                        "华兰生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物(002007)：流感疫苗高速放量 血制品业务逐步恢复",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "流感疫苗",
                        "高速放量",
                        "血制品业务",
                        "逐步恢复"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业月报：年报相继披露 关注高增长公司及A+H股医药投资机会",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "行业月报",
                        "年报披露",
                        "高增长公司",
                        "A+H股",
                        "医药投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "社保QFII持股路径曝光，化工电子板块各有所爱",
                "features": {
                    "keywords": [
                        "社保",
                        "QFII",
                        "持股路径",
                        "化工",
                        "电子板块"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工",
                        "电子"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}